| Pregabalin | hsa00500 | Starch and sucrose metabolism | 1.34E-02 | 3 | O43451, P46976, P06737 | MGAM, GYG1, PYGL | More | |
| Pregabalin | hsa00591 | Linoleic acid metabolism | 1.65E-02 | 1 | P11712 | CYP2C9 | More | |
| Pregabalin | hsa00604 | Glycosphingolipid biosynthesis - ganglio series | 1.34E-02 | 2 | P06865, Q9H4F1 | HEXA, ST6GALNAC4 | More | |
| Pregabalin | hsa00730 | Thiamine metabolism | 3.83E-02 | 2 | P05186, P24666 | ALPL, ACP1 | More | |
| Pregabalin | hsa00920 | Sulfur metabolism | 1.65E-02 | 1 | Q16762 | TST | More | |
| Pregabalin | hsa04071 | Sphingolipid signaling pathway | 4.27E-02 | 1 | Q02156 | PRKCE | More | |
| Pregabalin | hsa04122 | Sulfur relay system | 1.65E-02 | 1 | Q16762 | TST | More | |
| Pregabalin | hsa04142 | Lysosome | 2.98E-02 | 2 | P10619, P49281 | CTSA, SLC11A2 | More | |
| Pregabalin | hsa04270 | Vascular smooth muscle contraction | 4.59E-02 | 1 | Q02156 | PRKCE | More | |
| Pregabalin | hsa04610 | Complement and coagulation cascades | 4.69E-03 | 1 | P0C0L4 | C4A | More | |
| Pregabalin | hsa04650 | Natural killer cell mediated cytotoxicity | 4.40E-02 | 6 | P78314, P06239, O60880, P20963, P26718, O75015 | SH3BP2, LCK, SH2D1A, CD247, KLRK1, FCGR3B | More | |
| Pregabalin | hsa04658 | Th1 and Th2 cell differentiation | 9.73E-03 | 6 | P20963, P09693, Q16539, P06239, Q9UL17, P13765 | CD247, CD3G, MAPK14, LCK, TBX21, HLA-DOB | More | |
| Pregabalin | hsa04659 | Th17 cell differentiation | 7.42E-03 | 7 | Q16539, P06239, P13765, P14778, Q9UL17, P09693, P20963 | MAPK14, LCK, HLA-DOB, IL1R1, TBX21, CD3G, CD247 | More | |
| Pregabalin | hsa04666 | Fc gamma R-mediated phagocytosis | 4.59E-02 | 1 | Q02156 | PRKCE | More | |
| Pregabalin | hsa04750 | Inflammatory mediator regulation of TRP channels | 3.29E-02 | 1 | Q02156 | PRKCE | More | |
| Pregabalin | hsa04925 | Aldosterone synthesis and secretion | 3.62E-02 | 1 | Q02156 | PRKCE | More | |
| Pregabalin | hsa04930 | Type II diabetes mellitus | 9.93E-03 | 1 | Q02156 | PRKCE | More | |
| Pregabalin | hsa04931 | Insulin resistance | 2.64E-02 | 1 | Q02156 | PRKCE | More | |
| Pregabalin | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 2.31E-02 | 1 | Q02156 | PRKCE | More | |
| Pregabalin | hsa04974 | Protein digestion and absorption | 9.93E-03 | 1 | Q7Z2H8 | SLC36A1 | More | |
| Pregabalin | hsa05144 | Malaria | 1.44E-02 | 4 | P60033, O60603, P35443, P26718 | CD81, TLR2, THBS4, KLRK1 | More | |
| Pregabalin | hsa05150 | Staphylococcus aureus infection | 4.36E-02 | 2 | P0C0L4, P13646 | C4A, KRT13 | More | |
| Pregabalin | hsa05169 | Epstein-Barr virus infection | 4.41E-02 | 8 | P13765, Q13547, O00463, Q16539, P24522, O60603, P09693, P20963 | HLA-DOB, HDAC1, TRAF5, MAPK14, GADD45A, TLR2, CD3G, CD247 | More | |
| Pregabalin | hsa05214 | Glioma | 4.10E-02 | 2 | P09619, Q02750 | PDGFRB, MAP2K1 | More | |
| Pregabalin | hsa05218 | Melanoma | 1.34E-02 | 2 | P09619, Q02750 | PDGFRB, MAP2K1 | More | |
| Pregabalin | hsa05230 | Central carbon metabolism in cancer | 4.10E-02 | 2 | P09619, Q02750 | PDGFRB, MAP2K1 | More | |
| Pregabalin | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 4.03E-02 | 5 | P20963, P09693, P06239, O60603, Q16539 | CD247, CD3G, LCK, TLR2, MAPK14 | More | |
